Physician profile
Paul E Kudelko
NPI 1225027014
$155,631.11
in general payments reported to CMS, 2019-2025
37 companies · $69K in 2025
The $69K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,182 · 2020: $925 · 2021: $2,009 · 2022: $1,378 · 2023: $1,775 · 2024: $79K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $130K · Travel and Lodging: $14K · Food and Beverage: $6,377 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $129,659.19 |
| Travel and Lodging | $14,068.67 |
| Food and Beverage | $6,377.05 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $146,806.28 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $1,755.71 | 2019-2023 | Xarelto |
| Amgen INC. | $1,327.43 | 2019-2024 | Repatha |
| Inari Medical, INC. | $885.86 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $439.19 | 2019-2025 | |
| Shockwave Medical, INC | $438.06 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $421.03 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $408.68 | 2019-2024 | |
| Boston Scientific Corporation | $404.60 | 2019-2025 | Watchman Flx, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $379.91 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $294.90 | 2019-2023 | Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $275.49 | 2021-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $227.67 | 2021-2024 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $226.54 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $165.21 | 2019-2025 | Lifevest |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inquis Medical, INC. | $158.03 | 2025 | Aventus |
| Merck Sharp & Dohme LLC | $129.12 | 2023-2025 | Verquvo, Winrevair |
| Kiniksa Pharmaceuticals, LTD. | $118.15 | 2021-2023 | Arcalyst |
| Baxter Healthcare | $94.28 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Amarin Pharma, INC. | $83.78 | 2019-2021 | |
| Esperion Therapeutics, INC. | $79.61 | 2020-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $53.85 | 2024 | Arcalyst |
| Astellas Pharma US INC | $49.48 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $47.61 | 2021-2024 | |
| Lilly USA, LLC | $45.46 | 2022 | |
| Lundbeck LLC | $41.37 | 2019-2021 | |
| Abiomed | $41.30 | 2024 | Impella |
| Regeneron Healthcare Solutions, INC. | $39.68 | 2020-2021 | |
| Portola Pharmaceuticals, LLC | $28.82 | 2019 | |
| Hologic Sales and Service, LLC | $25.78 | 2025 | Aptima |
| Acist Medical Systems, INC. | $23.96 | 2023 | |
| Alnylam Pharmaceuticals INC. | $23.84 | 2024 | Onpattro |
| Surmodics, INC. | $23.01 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Straight, Sublime Microcatheter, 014, 65cm, Angle |
| Celonova Biosciences, INC. | $20.41 | 2019 | |
| Cardiac Dimensions, INC. | $19.11 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $18.96 | 2023 | Inpefa |
| Cashflow Solutions, LLC | $8.94 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kudelko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.